Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Maffezzini

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Urologic Oncology|April 28, 2009
Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladderSarel Halachmi, Boaz Moskovitz, Massimo Maffezzini, et al.
European Urology|December 25, 2016
Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart<sup>®</sup> and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)]Claus G Roehrborn, Andrea Tubaro, Francesco Montorsi, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 12, 2018
The pathologist's role in the detection of rare variants of bladder cancer and analysis of the impact on incidence and type detectionGuglielmo Mantica, Alchiede Simonato, Danelo E Du Plessis, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 1, 2006
Retropubic nerve and seminal sparing radical prostatectomy for recurrent bladder neck-prostatic urethra stricturesPierpaolo Graziotti, Guido Giusti, Mauro Seveso, et al.
Scandinavian Journal of Urology|January 9, 2018
Large bladder diverticula: a comparison between laparoscopic excision and endoscopic fulgurationMauro Pacella, Guglielmo Mantica, Massimo Maffezzini, et al.
World Journal of Urology|December 12, 2018
Developing a five-step training model for transperineal prostate biopsies in a naïve residents' group: a prospective observational randomised study of two different techniquesGuglielmo Mantica, Andrea Pacchetti, Roberta Aimar, et al.
The International Journal of Biological Markers|December 17, 2010
Osteopontin plasma level does not detect prostate cancer in patients referred for diagnostic prostate biopsyRoberto Puzone, Laura Paleari, Franco Montefiore, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2014
Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular gradingMichele Lodde, Christine Mian, Roman Mayr, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2014
Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular gradingMichele Lodde, Christine Mian, Roman Mayr, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 2, 2009
Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsiesSilvia Zanardi, Matteo Puntoni, Massimo Maffezzini, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Urologic Oncology|April 28, 2009
Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladderSarel Halachmi, Boaz Moskovitz, Massimo Maffezzini, et al.
European Urology|December 25, 2016
Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart<sup>®</sup> and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)]Claus G Roehrborn, Andrea Tubaro, Francesco Montorsi, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 12, 2018
The pathologist's role in the detection of rare variants of bladder cancer and analysis of the impact on incidence and type detectionGuglielmo Mantica, Alchiede Simonato, Danelo E Du Plessis, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 1, 2006
Retropubic nerve and seminal sparing radical prostatectomy for recurrent bladder neck-prostatic urethra stricturesPierpaolo Graziotti, Guido Giusti, Mauro Seveso, et al.
Scandinavian Journal of Urology|January 9, 2018
Large bladder diverticula: a comparison between laparoscopic excision and endoscopic fulgurationMauro Pacella, Guglielmo Mantica, Massimo Maffezzini, et al.
World Journal of Urology|December 12, 2018
Developing a five-step training model for transperineal prostate biopsies in a naïve residents' group: a prospective observational randomised study of two different techniquesGuglielmo Mantica, Andrea Pacchetti, Roberta Aimar, et al.
The International Journal of Biological Markers|December 17, 2010
Osteopontin plasma level does not detect prostate cancer in patients referred for diagnostic prostate biopsyRoberto Puzone, Laura Paleari, Franco Montefiore, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2014
Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular gradingMichele Lodde, Christine Mian, Roman Mayr, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2014
Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular gradingMichele Lodde, Christine Mian, Roman Mayr, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 2, 2009
Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsiesSilvia Zanardi, Matteo Puntoni, Massimo Maffezzini, et al.
Pageof 8